The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-2-(5-(3-Hydroxyphenyl)pent-2-en-4-ynamido)cyclohex-1-ene-1-carboxylic acid ID: ALA4096635
PubChem CID: 137654580
Max Phase: Preclinical
Molecular Formula: C18H17NO4
Molecular Weight: 311.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(/C=C/C#Cc1cccc(O)c1)NC1=C(C(=O)O)CCCC1
Standard InChI: InChI=1S/C18H17NO4/c20-14-8-5-7-13(12-14)6-1-4-11-17(21)19-16-10-3-2-9-15(16)18(22)23/h4-5,7-8,11-12,20H,2-3,9-10H2,(H,19,21)(H,22,23)/b11-4+
Standard InChI Key: QYZMXCUFLXBIQN-NYYWCZLTSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
21.0557 -4.1726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0546 -4.9921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7626 -5.4011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4723 -4.9917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4694 -4.1690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7608 -3.7637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1734 -3.7565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8795 -3.3453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5857 -2.9340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2949 -3.3400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0011 -2.9287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7103 -3.3346 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.9980 -2.1115 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.4165 -2.9234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1225 -3.3340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8266 -2.9263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8277 -2.1087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1186 -1.7006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4084 -2.1101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1217 -4.1512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4136 -4.5592 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.8290 -4.5605 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.7624 -6.2183 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 3 0
5 7 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 2 0
14 19 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
15 20 1 0
20 21 2 0
20 22 1 0
3 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 311.34Molecular Weight (Monoisotopic): 311.1158AlogP: 2.33#Rotatable Bonds: 3Polar Surface Area: 86.63Molecular Species: ACIDHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.98CX Basic pKa: ┄CX LogP: 2.54CX LogD: -0.94Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.59Np Likeness Score: 0.55
References 1. Bobileva O, Ikaunieks M, Duburs G, Mandrika I, Petrovska R, Klovins J, Loza E.. (2017) Synthesis and evaluation of (E)-2-(5-phenylpent-2-en-4-ynamido)cyclohex-1-ene-1-carboxylate derivatives as HCA2 receptor agonists., 25 (16): [PMID:28668361 ] [10.1016/j.bmc.2017.06.028 ]